Alireza Khalaj

Alireza Khalaj

Auto-generated profile, based on publicly available information

Alireza Khalaj

Obesity Treatment Center, Department of Surgery, Shahed University, Tehran, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2016 in JMIR Research Protocols
Verified
Journal Article
Open access
MBMaryam Barzin
Maryam Barzin
FHFarhad Hosseinpanah
Farhad Hosseinpanah
MMMohammad Ali Motamedi
Mohammad Ali Motamedi
PSParvin Shapoori
Parvin Shapoori
PAPeyman Arian
Peyman Arian
AKAlireza Khalaj
Alireza Khalaj
Obesity is a major health concern in the Middle East and worldwide. It is among the leading causes of morbidity, mortality, health care utilization, and costs. With bariatric surgery proving to be a more effective treatment option for overweight and obesity, the need for systematic assessment of different procedures and their outcomes becomes necessary. These procedures have not yet been described in detail in our region. We aim to undertake a prospective study evaluating and comparing several surgical bariatric procedures in an Iranian population of morbid obese patients presenting to a specialized bariatric center. In order to facilitate and accelerate understanding of obesity and its complications, the Tehran Obesity Treatment Study (TOTS) was planned and developed. This study is a longitudinal prospective cohort study in consecutive patients undergoing bariatric surgery. TOTS investigators use standardized definitions, high-fidelity data collection system, and validated instruments to gather data preoperatively, at the time of surgery, postoperatively, and in longer-term follow-up. This study has recruited 1050 participants as of September 2015 and is ongoing. This study will ensure creation of high-level evidence to enable clinicians to make meaningful evidence-based decisions for patient evaluation, selection for surgery, and follow-up care.

1 January 2017 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
MMMohammad Ali Kalantar Motamedi
Mohammad Ali Kalantar Motamedi
MBMaryam Barzin
Maryam Barzin
MEMohammadreza Ebrahimi
Mohammadreza Ebrahimi
REReza Ebrahimi
Reza Ebrahimi
AKAlireza Khalaj
Alireza Khalaj
INTRODUCTION: Mini-gastric bypass (MGB) is a bariatric surgical technique popular in many centers due to shorter duration, easier technique, and excellent weight loss results. However, it may be associated with postoperative malnutrition. This case describes the clinical course and unfortunate outcome of a morbidly obese patient who underwent MGB and developed malnutrition in the first postoperative year. PRESENTATION OF CASE: A 37 year-old female patient with a BMI of 44 kg/m 2 successfully underwent MGB surgery in June 2015 and was discharged uneventfully. She presented with lower extremity edema and generalized weakness 8 months later, with a blood albumin level of 3.1 g/dL, compared to a normal preoperative value. She was admitted and received a high-protein diet, and her clinical condition improved. Three months after her discharge, she was readmitted with the same complaints, as well as pancytopenia. She was also hypocupremic. After unsuccessful intensive supportive measures, she finally underwent revisional gastrogastrostomy. However, she developed signs and symptoms of profound liver failure postoperatively (albumin 1.8 g/dL; total bilirubin 7.5 mg/dL; prothrombin time 34 s) and pancytopenia persisted. All resuscitative measures were unsuccessful and she expired in July 2016. DISCUSSION: Multiple factors can contribute to postoperative malnutrition and liver dysfunction after MGB, including the presence of baseline liver disease, inadequate diet supplementation, leaving a too-short common small intestinal channel, and ethnic variations in small bowel length. These factors should also be considered when deciding to perform corrective surgery. CONCLUSION: Careful, individualized treatment and follow-up plans may help to prevent such catastrophic consequences. Highlights:

8 November 2023 in International Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
HZHamidreza Zefreh
Hamidreza Zefreh
RAReza Amani-Beni
Reza Amani-Beni
ESErfan Sheikhbahaei
Erfan Sheikhbahaei
FFFarnaz Farsi
Farnaz Farsi
SAShahrzad Ahmadkaraji
Shahrzad Ahmadkaraji
SSShahab Shahabi
Shahab Shahabi
Context: This review study aimed to investigate the definition, etiology, risk factors (RFs), management strategy, and prevention of insufficient weight loss (IWL) and weight regain (WR) following bariatric metabolic surgery (BMS). Evidence Acquisition: Electronic databases were searched to retrieve relevant articles. The inclusion criteria were English articles with adult participants assessing the definition, prevalence, etiology, RFs, management strategy, and prevention of IWL/WR. Results: Definition: The preferred definition for post-BMS IWL/WR are the terms "Lack of maintenance of total weight loss (TWL)>20%" and "weight change in percentage compared to nadir weight or weight loss". Prevalence: The exact prevalence of IWL/WR is still being determined due to the type of BMS and various definitions. Etiology: Several mechanisms, including hormonal/metabolic, dietary non-adherence, physical inactivity, mental health, and anatomic surgical failure, are possible etiologies of post-BMS IWL/WR. RFs: Preoperative body mass index (BMI), male gender, psychiatric conditions, comorbidities, age, poor diet, eating disorders, poor follow-ups, insufficient physical activity, micronutrients, and genetic-epigenetic factors are the most important RFs. Management Strategy: The basis of treatment is lifestyle interventions, including dietary, physical activity, psychological, and behavioral therapy. Pharmacotherapy can be added. In the last treatment line, different techniques of endoscopic surgery and revisional surgery can be used. Prevention: Behavioral and psychotherapeutic interventions, dietary therapy, and physical activity therapy are the essential components of prevention. Conclusions: Many definitions exist for WR, less so for IWL. Etiologies and RFs are complex and multifactorial; therefore, the management and prevention strategy is multidisciplinary. Some knowledge gaps, especially for IWL, exist, and these gaps must be filled to strengthen the evidence used to guide patient counseling, selection, and improved outcomes.

1 March 2023 in International Journal of Surgery
Verified
Journal Article
Open access
MBMaryam Barzin
Maryam Barzin
AEAmir Ebadinejad
Amir Ebadinejad
AAAli Aminian
Ali Aminian
AKAlireza Khalaj
Alireza Khalaj
FGFaranak Ghazy
Faranak Ghazy
BABehnaz Abiri
Behnaz Abiri
In patients with BMI greater than 50, sleeve gastrectomy (SG) may not be adequate to treat obesity. To determine whether one-anastomosis gastric bypass (OAGB) can provide better outcomes compared with SG in patients with BMI greater than 50, a systematic review and meta-analysis was conducted, including a total of nine retrospective studies with a total of 2332 participants. There was a significant difference in the percentage of excess weight loss [weighted mean difference (WMD): 8.52; 95% CI: 5.81–11.22; P<0.001) and percentage of total weight loss (WMD: 6.65; 95% CI: 5.05–8.24; P<0.001). No significant differences were seen in operative time (WMD: 1.91; 95% CI: −11.24 to 15.07; P=0.77) and length of stay in hospital (WMD: −0.41; 95% CI: −1.18 to 0.37; P=0.30) between the two groups. There were no significant differences between OAGB with SG in Clavien–Dindo grades I–III [odds ratio (OR): 1.56; 95% CI: 0.80–3.05], or grade IV complications (OR: 0.72; 95% CI: 0.18–2.94). The meta-analysis on remission of type 2 diabetes indicated a comparable effect between SG and OAGB (OR: 0.77; 95% CI: 0.28–2.16). The OAGB group had a significantly higher rate of remission of hypertension compared with the SG group (OR: 1.63; 95% CI: 1.06–2.50). The findings of this meta-analysis suggest that the OAGB accomplished a higher percentage of total weight loss and percentage of excess weight loss at short-term and mid-term follow-up but, there was no major difference between the OAGB and SG operations in terms of perioperative outcomes, complications, and diabetes remission.

1 January 2020 in Obesity Research & Clinical Practice
Verified
Journal Article
Closed access
MBMaryam Barzin
Maryam Barzin
AKAlireza Khalaj
Alireza Khalaj
ETErfan Tasdighi
Erfan Tasdighi
DNDanial Samiei Nasr
Danial Samiei Nasr
MMMaryam Mahdavi
Maryam Mahdavi
MVMajid Valizadeh
Majid Valizadeh

2 May 2021 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
MMMaryam Mousavi
Maryam Mousavi
MTMastaneh Rajabian Tabesh
Mastaneh Rajabian Tabesh
AKAlireza Khalaj
Alireza Khalaj
HZHassan Eini Zinab
Hassan Eini Zinab
SJSoodeh Razeghi jahromi
Soodeh Razeghi jahromi
MAMaryam Abolhasani
Maryam Abolhasani